Table 1.
Cancer Cell Line | Tumor Type | Mouse Strain | oHSV | References |
---|---|---|---|---|
CT26 | Colon carcinoma | BALB/c | G207 | [6,25,26] |
NV1020 | [26] | |||
oHSV2 | [19] | |||
OV-IL15C | [27] | |||
OncoVexmGMCSF | [28] | |||
mONCR-171 | [29] | |||
MC26 | Colon cancer | BALB/c | HF10 | [30] |
hrR3 | [31] | |||
MC38 | Colon cancer | C57Bl/6 | mONCR-171 | [29] |
N18 | Neuroblastoma | A/J | G207 | [24,32] |
Neuro-2a | Neuroblastoma | A/J | G207 | [33] |
G47Δ | [33] | |||
C134 | [34] | |||
M002 | [35] | |||
S91 Cloudman M3 | Melanoma | DBA/2 | G207 | [6] |
HSV1716 | [36] | |||
HF10 | [37] | |||
Harding–Passey | Melanoma | C57Bl/6 | HSV1716 | [38] |
D4M3A | Melanoma | C57Bl/6 | mT-VEC | [39] |
B16R | Melanoma | C57Bl/6 | oHSV2-aPD1 | [40] |
M6c | Breast cancer | C3(1)/T-Ag | G47Δ | [41] |
4T1 | Breast cancer | BALB/c | oHSV2 | [42] |
G47Δ-IL12 | [43] | |||
FusOn-H2 | [44] | |||
oHSV2 | [42] | |||
HSV1716 | [45] | |||
ΔN146 | [46] | |||
MMTV-PyMT-Ts1 | Breast cancer | FVB | HSV1716 | [45] |
005 | Glioblastoma | C57Bl/6 | G47Δ | [47] |
G47Δ-IL12 | [48] | |||
CT2A | Glioblastoma | C57Bl/6 | G47Δ-IL12 | [48] |
DBT | Glioblastoma | BALB/c | C134 | [34] |
4C8 | Glioblastoma | B6D2F1 | rQNestin34.5 | [49] |
M002 | [50] | |||
GL261N4 | Glioblastoma | C57Bl/6 | NG34scFvPD-1 | [51] |
SCC-VII | Squamous cell carcinoma | C3H/HeN | HF10 | [52] |
NV1020, NV1042 | [53] | |||
TC-1 | HPV+ cervical cancer | C57Bl/6 | G47Δ (T-01) | [54] |
Hepa1-6 | Hepatoma | C57Bl/6 | G47Δ (T-01) | [55] |
OVH-aMPD1 | [56] | |||
TRAMP-C2 | Prostate | C57Bl/6 | NV1023, NV1042 | [57] |
MBT-2 | Bladder | C3H/He | FusOn-H2 | [58] |
A20 | Lymphoma | BALB/c | OncoVexmGMCSF | [59] |
VG161 | [60] | |||
mRP2 | [61] | |||
mONCR-171 | [29] | |||
76-9 | Rhabdomyosarcoma | C57Bl/6 | HSV1716 | [62,63] |
M3-9-M | Rhabdomyosarcoma | C57Bl/6 | HSV1716 | [62,63] |